CN107119059B - Xanthine oxidase for clinical detection, coding gene thereof and application thereof - Google Patents

Xanthine oxidase for clinical detection, coding gene thereof and application thereof Download PDF

Info

Publication number
CN107119059B
CN107119059B CN201710262579.2A CN201710262579A CN107119059B CN 107119059 B CN107119059 B CN 107119059B CN 201710262579 A CN201710262579 A CN 201710262579A CN 107119059 B CN107119059 B CN 107119059B
Authority
CN
China
Prior art keywords
xanthine oxidase
solution
enzyme
xanthine
xod
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201710262579.2A
Other languages
Chinese (zh)
Other versions
CN107119059A (en
Inventor
闫达中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuhan Polytechnic University
Original Assignee
Wuhan Polytechnic University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuhan Polytechnic University filed Critical Wuhan Polytechnic University
Priority to CN201710262579.2A priority Critical patent/CN107119059B/en
Publication of CN107119059A publication Critical patent/CN107119059A/en
Application granted granted Critical
Publication of CN107119059B publication Critical patent/CN107119059B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/03Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)

Abstract

The invention relates to a xanthine oxidase gene, the sequence of which is SEQ ID NO 1 or a synonymous mutant thereof; also relates to a xanthine oxidase expression vector with high GC content; also relates to the xanthine oxidase coded by the xanthine oxidase gene and application thereof; also relates to a method for oxidizing hypoxanthine and xanthine.

Description

Xanthine oxidase for clinical detection, coding gene thereof and application thereof
Technical Field
The invention relates to the field of molecular biology, in particular to a xanthine oxidase gene, a xanthine oxidase coded by the xanthine oxidase gene, application of the xanthine oxidase gene, a xanthine oxidase gene expression vector, an expression strain and a method for oxidizing hypoxanthine and xanthine.
Background
Xanthine oxidase (Xanthine oxidase, abbreviated as XOD, EC 1.1.3.22) is widely present in tissues and cells of various organisms, is a cytoplasmic complex enzyme, is a key enzyme for purine metabolism of organisms, and belongs to a molybdenum enzyme family. At O2In the presence of XOD, molecular oxygen is used as a direct electron acceptor, and the oxidation reaction can be catalyzed without coenzyme. XOD is involved in almost all biochemical processes of cells, nucleotides are first degraded in vivo into nucleosides and phosphates, and nucleosides are decomposed into purine bases, pyrimidine bases and ribose under the action of nucleosidase. XOD catalyzes the oxidation of hypoxanthine and xanthine to uric acid and subsequent metabolism to urea according to the following equation:
Figure DEST_PATH_GDA0001344221110000011
in the reaction formula, (1) represents xanthine oxidase, (2) represents urate oxidase, (3) represents allantoin enzyme, and (4) represents allantoin enzyme
In the metabolic process, substances having important physiological functions such as superoxide or oxygen radicals are also produced, and are drawing attention in close relation to diseases such as ischemic reperfusion injury, hyperuricemia, gout, rheumatism, hepatitis, and arthritis.
At present, XOD has been developed into a commercial enzyme with a higher added value, and can be clinically used for preparing immune antibodies, tumor suppressors and detection and diagnosis reagents for diseases, mainly used for detecting xanthine, hypoxanthine and inosine (inosine), assisting in detecting guanine and guanosine, and also used for determining the activity of 5' -nucleoside phosphorylase, and is suitable for detecting hepatobiliary tumors. XOD is also widely used for detecting serum inorganic phosphorus level (hyperphosphatemia) and superoxide dismutase SOD activity. Therefore, the method has important theoretical significance and wide application prospect in the development and research of the xanthine oxidase XOD.
In addition, the content of hypoxanthine in the body of fish increases as its putrescence increases, so by measuring the change in hypoxanthine in the body, the freshness of fish can be determined. The xanthine oxidase can also be used for degrading carotenoid to prepare tobacco flavor.
The xanthine oxidase used at home and abroad at present is mainly obtained from milk. The source of the xanthine oxidase is single, the production cost is high, and the content and the quality of the xanthine oxidase are influenced by different regions and different types of cows, so that the xanthine oxidase is greatly limited in application.
Therefore, a novel xanthine oxidase gene and expression system are required.
Disclosure of Invention
In order to solve the above problems, the present invention provides a xanthine oxidase gene, the sequence of which is SEQ ID NO. 1 or a synonymous mutant thereof.
The invention also provides an expression vector of the xanthine oxidase, which comprises a xanthine oxidase expression cassette, wherein the xanthine oxidase expression cassette consists of a promoter and a xanthine oxidase gene connected to the downstream of the promoter, and the sequence of the xanthine oxidase gene is SEQ ID NO. 1 or a synonymous mutant thereof.
In a preferred embodiment, the promoter is an inducible promoter.
The invention also provides a recombinant strain for expressing the xanthine oxidase, which is obtained by transforming the expression vector of the xanthine oxidase gene into an expression host.
The invention also provides xanthine oxidase which is coded by the xanthine oxidase gene.
The invention also provides application of the xanthine oxidase in preparation of a reagent for detecting hypoxanthine and/or xanthine concentration.
The present invention also provides a method for oxidizing hypoxanthine and/or xanthine in a solution, comprising the step of adding to said solution the xanthine oxidase described above.
In a preferred embodiment, the pH of the solution is 6.0 to 9.0.
In another preferred embodiment, the temperature of the solution is from 25 to 55 ℃.
In another preferred embodiment, the solution is free of metal ions, or contains Mg2+、Ca2+、Mo6+、Co2+Or Mn2+
Drawings
Fig. 1 is an electrophoretogram of extracted YF06 genome;
FIG. 2 is an electrophoretogram of PCR product obtained by PCR amplification using YF06 genome as template and primers 1 and 2;
FIG. 3 is an electrophoresis diagram of EcoRI and HindIII double digestion detection recombinant plasmid pGEMT-xodAB-His;
FIG. 4 is an electrophoresis diagram of EcoRI and Hind III double digestion detection of recombinant plasmid pVLT 33-xodAB-His;
FIG. 5 is a XOD purification plot showing protein elution peak times;
FIG. 6 is an SDS-PAGE of pAW340[ pVLT33] and pAW340[ pVLT33-xodAB-His ] crude enzyme solutions purified of proteins 7, 8 and 9 collected, lanes 1,2 and 3 showing the higher concentrations of proteins 7, 8 and 9 collected after purification; lane 4 is crude enzyme solution before purification; lane 5 is control pAW340[ pVLT33 ]; m is a protein molecule marker;
FIG. 7 is a graph of a concentration standard curve prepared with BSA;
FIG. 8 is a pH-XOD viability curve;
FIG. 9 is a graph showing the enzyme activity curves of XOD after 16h at different pH values;
FIG. 10 is a graph of viability at temperature versus XOD;
FIG. 11 is a graph showing the activity of XOD after 30min at different temperatures;
FIG. 12 is a double reciprocal plot of the kinetics of the enzymatic reaction of XOD to catalyze the oxidation of xanthines.
Detailed Description
The principles and features of this invention are described below in conjunction with examples, which are set forth to illustrate, but are not to be construed to limit the scope of the invention.
1. Screening of XOD-producing strains
Collecting activated sludge in sewage treatment pools of various beer production enterprises, fully and uniformly mixing, respectively taking a small amount of samples, putting the samples into a clean and sterilized triangular flask, adding a proper amount of sterile water, performing shake culture on a shaking table for 2 days to fully release thalli in a soil sample, and centrifuging to take supernatant to obtain mother liquor containing microorganisms in the soil sample.
Adding 1mL of the mother solution into 50mL of the selection medium, and culturing for 7 days at 30 ℃ under shaking (180 r/min); then continuously subculturing for 4 times, taking 200 mu L of culture solution for gradient dilution, coating a selective culture medium plate, and culturing for 7 days at 30 ℃; and (3) when a single colony grows out, selecting the single colony to a solid inorganic salt selective culture medium, culturing at constant temperature of 30 ℃, selecting a colony with a larger hydrolysis ring, obtaining an arthrobacter strain YF06 in the screening process, and performing further identification.
2. Extracting XOD from YF06
1) Inoculating YF06 into sterilized 1/4 nutrient medium, culturing at 170r/min and 30 deg.C for 24 h;
2) each of the four flasks contained 100mL of 1/4 nutrient medium was added with 1mL of the culture medium, and after culturing for 48 hours, the OD was measured600The value is 0.6-0.8, and xanthine is added for induction for 24 hours;
3) centrifuging the above 400mL culture at 8000r/min for 10min, discarding supernatant to obtain precipitate, suspending the precipitate with 15mL50mM Tris-HCl (pH 7.5), and performing ultrasonic cell disruption at 0 deg.C and ultrasonic power of 400w and ultrasonic frequency of 2s at an interval of 2s for 25 min. After the crushing is finished, centrifuging for 15min at 0 ℃ and 12000rpm, and removing cell fragments to obtain cell crushing liquid supernatant;
4) the obtained supernatant was added slowly with ammonium sulfate solid at 0 ℃ until saturation became 45%, the mixture was stirred while adding, salting out was carried out overnight, centrifugation was carried out at 8000rpm for 15min, the supernatant was removed, a minimum volume of enzyme buffer Tris-HCI buffer (50mM, pH 7.5) was added to the precipitate to completely dissolve it, and the obtained solution was determined to have XOD enzyme activity, and it was found that XOD enzyme-encoding gene was likely to be present in the genome of YF 06.
3. Isolation of XOD enzyme encoding Gene from Strain YFO6
Extracting YF06 genome with Premega genome extracting kit, and gel electrophoresis detecting small amount of DNA. The results are shown in FIG. 1, where the extracted genome is relatively complete. For a single type of DNA sample of the same kind, the amount of the nucleic acid dye embedded is proportional to the DNA content of the sample solution, the extracted DNA brightness is about 3 times of that of Marker, and the DNA concentration can be calculated from the amount of the Marker added. Using a micro ultraviolet spectrophotometer to determine the DNA concentration of 5ug/ml and DNAOD260/OD280The ratio of (A) to (B) was about 1.71, and the purity was proved to be good.
Downloading XOD size subunit gene sequences in an NCBI GenBank database, carrying out multi-sequence comparison by using clustalw2, and designing primers capable of amplifying XOD in upstream and downstream conserved regions of the XOD gene by using Primer5.0 software. The sequences of the primer pairs are respectively shown as SEQ ID NO. 2 and SEQ ID NO. 3.
Primer 1: 5'-GAATTCCATG TGGCCCGCGCTGACCGTCACC-3' (SEQ ID NO: 2);
primer 2: 5'-AAGCTTTCA GTG GTG GTG GTG GTG GTG GCCCATCGGGCCCACGGTGT-3' (SEQ ID NO: 3).
YF06 is used as a template, primers 1 and 2 are used for PCR amplification, an amplification product is detected by 0.8% agarose gel electrophoresis, the result is shown in figure 2, a band is obviously seen below 5000 and is consistent with the size of an expected target gene, the sequence is shown as SEQ ID NO. 1 after sequencing, the amplification product XOD is used for encoding a gene xodAB, and the GC content in the amplification product XOD is more than 75%.
4. Construction of recombinant expression plasmid pVLT33-xodAB-His
And (2) carrying out agarose gel electrophoresis recovery on the PCR product, connecting the product with A. tailing product to pGEMT-easy vector, transferring into DH5 α, coating on an LB solid plate containing ampicillin, culturing at 37 ℃ for 12h, randomly selecting transformant, inoculating the transformant into 3mL of liquid LB culture medium, extracting plasmid by using an alkaline lysis method after 12h at 37 ℃, and carrying out enzyme digestion to identify the transformant, wherein the result is shown in figure 3, the size of the pGEMT-easy vector is 2867bp, the size of the xodAB gene is 3597bp, two bands are observed behind the plasmid extracted by enzyme digestion and are matched with the sizes of the pGEMT-easy vector and the gene xodAB, therefore, the xodAB is successfully cloned to the pGEM-T vector, is sent to the marine engineering for sequencing, and the correct recombinant plasmid is named as pGEMT-xodAB.
The correct transformants were plated, a single colony was picked and inoculated on LB (ampicillin-containing) for 12h at 37 ℃, plasmids were extracted with the kit, and after double digestion, gel electrophoresis was performed to recover xodAB gene fragments, the recovered target gene was ligated to pVLT33 vector recovered by EcoRI/HindIII double digestion, and transformed into E.coli DH5 α, which was spread on a solid LB (kanamycin 50. mu.g/mL) plate, and after 12h of culture, a single colony was randomly picked and inoculated on 5mL of liquid LB (kanamycin, 37 ℃, 12h after boiling to extract plasmids, and transformants were identified by double cutting with EcoRI and HindIII, as shown in FIG. 4, pVLT33 vector was 9.7kb in size, XOD gene xodAB was 3597bp in size, and from this figure, two bands after digestion of the plasmid were observed, which coincided with vector pVLT33 and gene xodAB, and thus, xodAB was successfully cloned on vector VLT 33.
5. Construction of expression Strain
And (3) coating a plate with a correctly identified transformant, selecting a single colony, extracting a plasmid by a boiling method, and transferring the recombinant plasmid into pAW340 to obtain the expression strain.
Centrifuging the induced bacterial liquid, performing ultrasonic disruption, centrifuging at 4 ℃ and 12000rpm for 15min, and removing cell debris to obtain the crude cell enzyme liquid. And (4) taking the crude enzyme liquid of the cells to measure the enzyme activity, and measuring that the shake flask fermentation yield of the engineering bacterium enzyme is 1.52U/mL. The obtained re-engineered strain was found to be active XOD.
6. Purification of xanthine oxidase
The crude enzyme solution of recombinant engineered bacterium pAW340[ pVLT33-xodAB-His ] for inducing expression is added with imidazole (0.005M) and NaCl (0.5M) for filtration, and then protein is purified by His Trap nickel column. During the collection of the purified enzyme, starting from the increase in the volume of solution B, one tube was collected per 1 mL. Purification as shown in FIG. 5, it can be seen that No. 5 to No. 10 represent the time periods of peak appearance, and no miscellaneous peaks appear. Taking pAW340[ pVLT33] and pAW340[ pVLT33-xodAB-His ] crude enzyme solutions and 20 μ L of purified and collected proteins No. 7, 8 and 9, adding 5 Xloading buffer solution, boiling in boiling water for 10min, centrifuging, taking supernatant, and performing SDS-PAGE gel detection, wherein the results are shown in figure 6, and lanes 1,2 and 3 are proteins No. 7, 8 and 9 with higher concentration collected after purification; lane 4 is crude enzyme solution before purification; lane 5 is control pAW340[ pVLT33 ]; m is protein molecular weight marker.
After collection, the activity of each tube is measured, and No. 7, No. 8 and No. 9 with higher activity are selected to be centrifuged for 3min at 7000 rpm of an ultrafiltration centrifuge tube. The purified enzyme solution was stored in two tubes.
The absorbance at 595nm was measured using BSA standard solutions at different concentrations and a standard curve was plotted, as shown in FIG. 7, for BSA standards at concentrations ranging from 10-50. mu.g/mL and A595The standard curve equation is that y is 0.012x +0.008, R is20.993, can be used for protein concentration calculation. pAW340[ pVLT33-xodAB-His ] after purification was calculated from a standard curve]The concentration of the protein sample of (2) was 26. mu.g/mL.
Determination of XOD enzyme Activity
Xanthine oxidase in the course of catalyzing the reaction of xanthine oxidation, 1mol of oxygen and water will be consumed per 1mol of xanthine oxidized to produce 1mol of uric acid and 1mol of H2O2. Uric acid has a maximum absorption peak at 293 nm. The uric acid concentration can be determined by detecting the absorbance of the solution at 293nmAnd thus the XOD enzyme activity is determined by the change in concentration.
The pure enzyme solution was added to the solution containing xanthine and measured at the absorbance at 293nm with an ultraviolet spectrophotometer. The activity of the xanthine oxidase is determined according to the ultraviolet absorption condition of the reaction product uric acid by carrying out detection every 30 s.
1U of enzyme activity is defined as the amount of enzyme required to produce 1. mu. mol of uric acid in one minute is 1U. The enzyme activity determination experiment adopts a method for determining enzyme activity on a product specification, and specifically comprises the following reagents and steps:
A.Tris-HCl buffer,pH 7.5 :0.1M
B.Sodium hydroxide solution :0.0025M
C.Xanthine solution :10mM
D.Oxonic acid potassium salt solution :1mM
E.Enzyme diluent :50mM Tris-HCl buffer,pH7.5
adding 2.24ml of solution A, 80 μ L of solution C and 80 μ L of solution D into an ultraviolet quartz cell, gently blowing, bathing at 37 deg.C for 45min, adding crude enzyme solution into the mixed solution, measuring the absorbance change at 293nm in an ultraviolet spectrophotometer, and recording the OD once every 30 seconds293And changing and recording data.
According to the calculation formula of enzyme activity provided in Japanese "TOYOBO ENZYMES" document:
Figure DEST_PATH_GDA0001344221110000081
Volume activity(U/ml)=ΔOD/min×2.0×df
Weight activity(U/mg)=(U/ml)×1/C
wherein the meaning of each symbol or number is as follows: vt is the total volume (2.5 ml); vs is the sample volume (0.1 ml); 12.5 absorption coefficient per millimole of uric acid (cm) under the detection conditions2mu.M; 1.0 is the optical path length (cm); df is the dilution factor; c is the lytic enzyme concentration (mg/ml).
1) Effect of pH on XOD enzyme Activity and stability
Preparing enzyme detection solution with buffer solutions with different pH values (pH 4.0-10.0), measuring enzyme activity according to the method, and determining the optimum pH value of XOD reaction. Diluting the enzyme solution with buffer solutions with different pH values (pH4.0-11.0), keeping the temperature at 25 ℃ for 15h, and then measuring the residual enzyme activity. A curve of pH and enzyme activity was prepared by using the enzyme activity of XOD at the optimum pH, and the pH stability of XOD was examined.
The activity of XOD was measured at 37 ℃ in each of the buffers at pH4.0 to 10.0, and as shown in FIG. 8, the enzyme activity was 0 at pH4.0, and the xanthine oxidase activity gradually increased with increasing pH, reaching a maximum value at pH 8.0. The decrease then started and the activity disappeared at pH 10.0. Therefore, the enzyme has activity between pH 6 and 9, and the optimum reaction pH of the enzyme is 8.0.
The enzyme solution was added to buffers of different pH values, and after incubation at 25 ℃ for 16 hours, the residual enzyme activity was measured, and the results are shown in FIG. 9, in which the xanthine oxidase had no activity at pH4.0-5.0, and then the enzyme activity increased with increasing pH, and the enzyme reached the maximum value at pH8.0, from which it was found that the xanthine oxidase had the best stability in Tris-HCl buffer at pH 8.0.
2) Effect of temperature on XOD enzyme Activity and stability
In a buffer solution with the pH value of 7.5, enzyme activity at different temperatures is measured according to the method, and the optimum reaction temperature of XOD is determined. The enzyme solution is respectively kept at 30 ℃, 40 ℃, 50 ℃, 55 ℃, 60 ℃ and 70 ℃ for 30min, is rapidly cooled to room temperature, the residual enzyme activity is measured, and a temperature-enzyme activity curve is prepared, wherein the result is shown in figure 10, the enzyme activity change is not obvious between 30 ℃ and 50 ℃, 60 ℃ and 80 ℃, and the activity reaches the highest at 55 ℃.
And (3) keeping the enzyme solution at different temperatures for 30min, determining the change condition of the enzyme activity, and researching the thermal stability of the XOD. As a result, as shown in FIG. 11, the temperature greatly affected the stability of xanthine oxidase. The enzyme activity is basically not lost after 30min of treatment at the temperature of 30-50 ℃, and the enzyme basically loses the activity after 30min of treatment at the temperature of 60 ℃.
3) Determination of kinetic constants of XOD
Xanthine with different concentrations of 0.08, 0.16, 0.2, 0.32, 0.4mM, etcThe XOD enzyme activity of the substrate is measured, and the influence of the substrate on the enzymatic reaction speed is observed. According to the Lineweaver-Burk (double reciprocal mapping method) as shown in fig. 12, the linear equation is (1/V) ═ 0.5091 × (1/S) +7.6272, and the correlation coefficient R2The Michaelis constant Km of xanthine oxidase was 0.06675mM, and the maximum reaction rate was 0.1303mM ∙ min, to obtain 0.9958.
4) Effect of Metal ions on XOD enzymatic Activity
Different metal ions (final concentration of 2mM/L) were added to the enzyme solution, and the residual enzyme activity was measured after incubation at 25 ℃ for 2 hours. Relative enzyme activity was calculated using an enzyme solution without added metal ions as a control. The results are shown in Table 1, the metal ion Mg2+、Ca2+Has slight promoting effect on xanthine oxidase activity, Co2+、Mn2+、Ba2+Has certain inhibition effect on enzyme activity. And adding Ag into the reaction system+、Hg2+、 Pb2+、Zn2+、Cu2+、Fe2+、Fe3+No enzyme activity was detected after ionization and a significant precipitate was seen. The reason for analysis is that the reaction system is very insoluble in water, and the reaction system is made up of 0.025M/L NaOH to prepare a xanthine solution, so Ag+、Hg2+、Pb2+、Zn2+、Cu2+、Fe2+、Fe3+The plasma metal ions are all reacted with OH-The reaction produced a precipitate.
TABLE 1 Effect of different Metal ions on enzyme Activity
Figure DEST_PATH_GDA0001344221110000101
Sequence listing
<110> Wuhan university of light industry
<120> xanthine oxidase capable of being used for clinical detection, encoding gene thereof and application thereof
<130>1
<160>3
<170>PatentIn version 3.5
<210>1
<211>3596
<212>DNA
<213> Arthrobacter
<400>1
atgtggcccg cgctgaccgt caccgacgag ggcctcgaga tcgccgcgac gtgcaccgtc 60
gccgagctgt gggcgttcga ggagagcgcg caggccgcgc ccgtgcgcga ccggtggcgc 120
gcgctggacc tcgtgcggcc gtgctgcgac agcttcgtcg cgtcgttcaa gatctggaac 180
acgtcgaccg tcgggggcaa cgtctgcacg tccctgccgg ccgggccgat gatctcgctc 240
accgcggcgc tcgacggggt cgcggaggtc tgggggccgg gcgggacccg gcgggagcag 300
cccgtcgtcg acctcgtcac gggcgaggtg cgcaacacgc tcgcgcccgg ggagctcctg 360
cgcgcgatcc gcctgccgga ccacgcgctg cgctcgcgca cggcgttccg ccgcctgtcg 420
ctgtcgaacc tcgggcgctc cggcgtgctg ctcttggggc gggtcgaccc gcccgacgcc 480
gggggcgcct tcgtcctcac ggtcaccgcc tcgacgcgcc ggcccgtgca gctccgtttc 540
gcggcggacg cgctgcccac cgccgccgac ctcgtcgcca cgctcgacgc cgcgatcccc 600
gccgacctct accacgacga catccacggg ctgcccgagt ggcgccggga catgacctac 660
cgcctcggcg agcagatccg cgcggagctc gtcgacggca cgacctcgga cggaggcctc 720
cgatgacgac gacgcccgcc tcgcacccgg tcccgccggt gacgatcgac ggtcgcacgg 780
cacgcaccga gccccgcgca ggccagtgcc tgcgcaccta cctgcgcgag cagggcgcgc 840
tcggcgtgaa gaaggggtgc gacggcggcg actgcggcgc gtgcaccgtg cacgtcgacg 900
gcgtcccggt gcactcgtgc gtctaccccg cgcggcgcgc ggcgggccac gaggtgacga 960
ccatcgaggg gctcgcggcg acgtcgtgcc cgggcggtgc cgccggggac gagccggcgg 1020
gcgcgtgcga ccacgacccc cacggcccgc aggacgcgct gcacccggtg cagcagcagt 1080
tcctcgacgc gcagggcttc cagtgcgggt tctgcaccgc cgggatgatc atgaccgccg 1140
cgacgttcga cgacgcgcag cgcgagaacc tgccgcgcaa cctcaagggc aacctgtgcc 1200
gctgcacggg gtaccgcgcg atcgaggacg cggtcctcgg gcgcggcgac acgaccggga 1260
ccgcgccggg cacgggcgag cgtgcgccgt cgggcggcga ccgggcctct acctcgccgg 1320
accacggctc tacctcggcg gaccacggct ctacctcgcc ggaccggggc tctccctcgg 1380
cggagcaggg ctctggcgag gcgggccggg cgttcgggcg cgacgtgccc gcgcccgcgg 1440
gccgggggat cgtcaccggg acggtgcggt acacgctcga cgtggacccg gccgactacc 1500
cgggcctgct ccacctcaag ctcgtgcggt cgccgcacgc gcacgcgcgc gtcgtcgcga 1560
tcgacacgac ggacgcgctc gcggtgcccg gcgtgcacgc cgtcctcacg cacgaggacg 1620
cgcccgcgac gcggttctcg accgcgcagc acgagctgtt caccgacgac cccgacgaca 1680
cgcggatcct cgacgacgtc gtgcggcacg tcggccagcg ggtcgcggcc gtcgtcgccg 1740
agaccgtcgc cgccgccgag gagggggtgc gccgggtccg cgtcgagtac gcgccgctgc 1800
ccgccgtcgt cgacccggag gaggccatgg ccccgggggc gccgctcgtg caccccgagc 1860
tcgacgccgc cgccgcgcgc gtctcgcggc cggaggcgaa cgtcgtcgcc gaggtgcaca 1920
gcgagctcgg cgacgtcgag cgcgggctcg cggaggccga cgtcgtgcac gaggccacgt 1980
accgcaccca ccgcgtgcag cacgccgcgc tcgagacgca ctgcgccgtc gcgtccctcg 2040
acgacgacgg gcggctcgtc gtgcggtcgt ccacgcaggt cccgttcctc gcgcgccgcc 2100
acctggcgcg cgtcctcgac ctcgacccgg agcgcgtgcg cgtgcactgc gagcgcgtcg 2160
gcggcgggtt cggcggcaag caggaggtgc tcacggagga cgtcgtcgcg ctcgcgacgc 2220
tgcggctcgg ccggcccgtg cagctcgagc tcacgcgccg cgagcagttc gtcggcacga 2280
cgacgcgcca cccgttccgc atccgcgtgc gcgcgggcgc gcgccgcgac ggcactctca 2340
cggcgctgca cctcgacgtc ctcagcaaca ccggggcgta cgggaaccac ggcccgggcg 2400
tcatgttcca cgggtgcggc gagtccctcg ccgtctatcg gtgcgacaac aagaaggtcg 2460
acgcccactg cgtctacacg aacaccgtgc ccgcgggcgc gttccgcggg tacgggctgt 2520
cgcagatgat cttcgcggtc gagtccgcgg tggacgagct cgcgcggcag ctcgggatgg 2580
acccggtcga gctgcggcgc cgcaacgtcg tgcgcgacgg cgaccccatg ctctccacgc 2640
acccgacgcc cgaggaggac gtgctctacg gcagctacgg gctcgaccag tgcctcgacc 2700
tggccgccga cgcgctcgcg cgcggccggg cgcgcgacgt cgccgcgtac ggcgcgggcg 2760
ccgggtcggg gccggacgtg ctgccggacc tcggcccgga gtggggcgtc ggggagggga 2820
cggcactgtc catgatcgac accgtcccgc cccgggggca ctactcccac gcgcgcgtgc 2880
ggctgcggcc ggacggggtc gtggtggccg aggtcgggac cgccgagttc ggcaacggca 2940
cgacgaccgt ccacgcgcag ctcgtcgcga gcgcgctcgg gcaggacgcc gccgacgtcg 3000
tcgtgcgaca gtccgacacc gacctcgtcg agcacgacac cggggcgttc ggctccaccg 3060
gcacggtcgt cgcgggcaag gcgtcgctcg ccgccgcgca ggacctggcc gaggccgtgc 3120
tcaaggtcgc ggccggggtc gcgggcgccg cgcccggcga ctgccggctc gtgcccggcg 3180
gcgtcgactg cgccgggacg gtgctgccgc tgaccgacgt cgcgcgtgcc gccgacgacg 3240
ccgggatcgc gctcgtcgcc gagggccgct ggggcggcac cccgcgctcg gtcgcgttca 3300
acgtccacgg cttccgcgtc gcggtgcacc gcgggacggg ggagatccgc atcctccagt 3360
ccgtccaggc cgccgacgcc ggggaggtcg tcaacccgcg ccagtgccgc ggccaggtcg 3420
agggcggcat cgcgcaggcc ctcggcgcgg cgctctacga gaacgtggtg gtcgacgaga 3480
cgggccgcgt gacgaccgac atcttccgcc agtaccacct gcccacgttc gcggacaccc 3540
cgcgcagcga ggtgtacttc gcgcggacgt cggacaccgt gggcccgatg ggctga 3596
<210>2
<211>31
<212>DNA
<213> Artificial sequence
<400>2
gaattccatg tggcccgcgc tgaccgtcac c 31
<210>3
<211>47
<212>DNA
<213> Artificial sequence
<400>3
aagctttcag tggtggtggt ggtggtggcc catcgggccc acggtgt 47

Claims (6)

1. A recombinant strain for expressing xanthine oxidase is obtained by transforming an expression vector containing a xanthine oxidase expression cassette into an expression host, wherein the xanthine oxidase expression cassette consists of a promoter and a xanthine oxidase gene which is connected to the downstream of the promoter, the sequence of the xanthine oxidase gene is SEQ ID NO. 1 or a synonymous mutant thereof, and the expression host is recombinant engineering bacteria pAW 340.
2. A xanthine oxidase expressed by the recombinant strain according to claim 1.
3. Use of the xanthine oxidase of claim 2 for the preparation of a reagent for detecting the concentration of xanthine and/or hypoxanthine.
4. A method of oxidizing xanthine and/or hypoxanthine in a solution, comprising the step of adding to said solution the xanthine oxidase of claim 2.
5. The method of claim 4, wherein the temperature of the solution is 25-55 ℃ and the pH of the solution is 6.0-9.0.
6. The method of claim 4 or 5, wherein the solution is free of metal ions or comprises Mg2+、Ca2+、Mo6+、Co2+Or Mn2+
CN201710262579.2A 2017-04-20 2017-04-20 Xanthine oxidase for clinical detection, coding gene thereof and application thereof Active CN107119059B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710262579.2A CN107119059B (en) 2017-04-20 2017-04-20 Xanthine oxidase for clinical detection, coding gene thereof and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710262579.2A CN107119059B (en) 2017-04-20 2017-04-20 Xanthine oxidase for clinical detection, coding gene thereof and application thereof

Publications (2)

Publication Number Publication Date
CN107119059A CN107119059A (en) 2017-09-01
CN107119059B true CN107119059B (en) 2020-03-20

Family

ID=59725306

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710262579.2A Active CN107119059B (en) 2017-04-20 2017-04-20 Xanthine oxidase for clinical detection, coding gene thereof and application thereof

Country Status (1)

Country Link
CN (1) CN107119059B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109735511B (en) * 2018-09-06 2022-03-29 西安文理学院 Preparation method of xanthine oxidase for clinical detection
CN110887795A (en) * 2019-11-15 2020-03-17 吉林大学 Molybdenum monoatomic nanoenzyme material and application thereof in xanthine colorimetric sensing

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105734027A (en) * 2014-12-11 2016-07-06 清华大学 Xanthine dehydrogenase, and coding gene thereof and application

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6455430B2 (en) * 2013-07-16 2019-01-23 東洋紡株式会社 Xanthine oxidase gene and the amino acid sequence encoding it

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105734027A (en) * 2014-12-11 2016-07-06 清华大学 Xanthine dehydrogenase, and coding gene thereof and application

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"产黄嘌呤氧化酶节杆菌X7产酶条件优化";夏小花等;《河南工业大学学报 (自然科学版 )》;20070430;第28卷(第2期);第51-54页 *
"节杆菌黄嘌呤氧化酶的发酵、纯化、特性及基因研究";李忠琴;《中国学位论文全文数据库》;20090331;全文 *

Also Published As

Publication number Publication date
CN107119059A (en) 2017-09-01

Similar Documents

Publication Publication Date Title
CN107502647B (en) Method for preparing L-glufosinate-ammonium by racemization removal with biological enzyme method
JP2007289148A (en) Method for producing glucose dehydrogenase derived from aspergillus oryzae
CN102191291B (en) Method for producing L-ornithine hydrochloride by genetic engineering bacteria
CN107119059B (en) Xanthine oxidase for clinical detection, coding gene thereof and application thereof
CN107217043B (en) Lactobacillus plantarum D-lactate dehydrogenase, and coding gene and application thereof
JP2729628B2 (en) Method for preparing glucose dehydrogenase from macrobacteria
JP4179384B2 (en) Process for producing glucose dehydrogenase from Aspergillus oryzae
CN114736879A (en) Glucose oxidase GoxM10 mutant E361P with improved heat stability and derivative mutant and application thereof
CN107955806B (en) Preparation method and application of superoxide dismutase Cu, Zn SOD (superoxide dismutase) from deep-sea cucumber
CN113493799B (en) Aspergillus niger strain for high yield of acid lactase
JP4292486B2 (en) Glucose dehydrogenase from Aspergillus oryzae
CN114736880B (en) Mutant D497N of glucose oxidase GoxM10 with improved acid stability as well as derivative mutant and application thereof
CN114736881B (en) Glucose oxidase GoxM10 mutant A4D with improved acid stability and derivative mutant and application thereof
CN102234624B (en) Genetic engineering strain for expression and generation of bacillus subtilis arginase, and constructing method thereof
CN115948363B (en) Tn5 transposase mutant and preparation method and application thereof
CN114934062B (en) Engineering bacterium for efficiently expressing D-psicose 3-epimerase and application
CN111206011A (en) Recombinant corynebacterium glutamicum and application thereof in production of L-glutamic acid
CN113481186B (en) GH18 chitinase ChiA and application thereof
CN113088501A (en) Glutamic acid dehydrogenase mutant for producing L-glufosinate-ammonium and L-glufosinate-ammonium production method
CN110551697A (en) Application of ergothioneine synthetase PEGT1 and PEGT2 of Pleurotus ostreatus in synthesis of ergothioneine
CN112522125B (en) Hyaluronidase engineering bacterium and construction method and application thereof
CN113698790A (en) Method for extracting indigo from indigo pigment engineering bacterium fermentation liquor
CN109055330B (en) Recombinant FAD synthetase, encoding gene, engineering bacterium and application thereof
CN104726471A (en) L-glutamate oxidase gene from streptomyces diastatochromogenes as well as preparation method and application thereof
CN110904102A (en) Promoter for recombinant protein expression

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant